Skip to content

Driving skill after Intravenous sedation using a Virtual Environment- Endoscopy

Evaluation of Driving Skills Using a Driving Simulator after Sedation Upper Gastrointestinal Endoscopy: A Comparative Study of Remimazolam and Midazolam - DRIVE-ENDO study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs071250026
Enrollment
40
Registered
2025-05-26
Start date
2025-07-11
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing upper gastroint estinal endoscopy with sedation. Upper gastrointestinal endoscopy

Interventions

Sponsors

Yamaguchi Daisuke
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients whose written consent was already obt ained with free will. 2) Japanese patients who are 18 years of age or older and have a regular driver's license at the time of consent 3) Patients scheduled to undergo upper gastroint estinal endoscopy with sedation.

Exclusion criteria

Exclusion criteria: 1) Patients scheduled to undergo endoscopic pro cedures. 2) Patients with a history of surgery on the upper digestive tract. 3) Patients on dialysis. 4) Patients consuming more than 60 grams of alcohol per day. 5) Patients who have severe liver dysfunction. 6) Patients with III/IV class of ASA-PS. 7) Patients who can not independently walk. 8) Patients who regularly use benzodiazepines, an algesics or central nervous system depressant. 9) Patients who have acute angle-closure glaucoma. 10) Patients who have myasthenia gravis. 11) Patients who are in pregnancy or under breast feeding. 12) Patients with a history of hypersensitivity to benzodiazepines or flumazenil, and patients with conditions or symptoms for which administration of these drugs is contraindicated. 13) Patients whom the investigator determines to be inappropriate for inclusion in the study

Design outcomes

Primary

MeasureTime frame
Group differences in change in driving reaction time before and 1 hour after sedated endoscopy

Secondary

MeasureTime frame
(1) Sedation success rate of sedation with a upper endoscopy MOAA/S score of 4 or less. (2) Total remimazolam and midazolam dose required to complete the upper endscopic procedure. (3) Time from completion of endoscopy to ability to leave(MOAA/S score is 5,Modified Aldrete score is 9 or more). (4)Trail Making Test Japanese Version (TMT-J) Part A Results Before and One Hour after sedated upper endoscopy. (5)Driving Simulator Test results before and one hour after sedated upper endoscopy (Steering Operation Speed, Operational Accuracy, Divided Attention to Multiple Tasks, Overall Evaluation)

Contacts

Public ContactDaisuke Yamaguchi

Saga University Hospital

daisukehawks@gmail.com+81-952-34-2361

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026